Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Tylosin
Elanco GmbH
QJ01FA90
Tylosin
200 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
tylosin
Authorised
1988-10-01
Health Products Regulatory Authority 12 June 2020 CRN009RCS Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Tylan 200, 200 mg/ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance Tylosin (as the base) 200 mg/ml Excipient Benzyl Alcohol 40 mg/ml For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. A sterile yellow solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Tylan 200 mg/ml Solution for Injection is indicated for use in cattle and pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES TYLAN 200 mg/ml Solution for Injection is indicated in all conditions associated with bacteria sensitive to tylosin which includes organisms in the following genera: Streptococcus Campylobacter Bacillus Spirochaetes Staphylococcus Fusiformis Corynebacterium Pasteurella Clostridium Chlamydia Erysipelothrix TYLAN 200 mg/ml Solution for Injection has been successfully used in respiratory and genito-urinary tract infections, otitis, cellulitis and secondary bacterial conditions associated with virus disease or post-operative infections. Specific disease entities treated successfully with TYLAN include Swine Dysentery, Erysipelas and Enzootic Pneumonia in pigs, foul in the foot, mastitis and calf pneumonia in cattle. For the prevention and control of enzootic pneumonia, swine dysentery and other scours caused by organisms sensitive to tylosin, in pigs. For the control of pneumonia in cattle associated with mycoplasmata and _Pasteurella multocida _sensitive to tylosin. 4.3 CONTRAINDICATIONS Tylan 200 should not be given to chickens or turkeys. Do not use in animals with known hypersensitivity to the active ingredients. Do not use in equine animals. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Health Products Regulatory Authority 12 June 2020 CRN009RCS Page 2 of 4 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use of this product should be base Read the complete document